Cantor Fitzgerald Starts Bruker (BRKR) at Buy

After the close, Cantor Fitzgerald initiated coverage on Bruker (NASDAQ: BRKR) with a Buy. PT $16.00.

The firm comments, "In our view, the company is well positioned to capitalize on high-growth market segments over the next several years and deliver above-market top line growth, leveraging internal R&D and strategic tuck-ins. Additionally, with below sector average margins, Bruker has significant upside for margin expansion in the medium-term." Cantor also sees high barriers to entry as the company develops high-end scientific instrumentation.

For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.

Shares of Bruker closed at $13.39 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• Bruker takes minority stake in AI lab startup Atinary Technologies
• Jefferies Starts Aehr Test Systems (AEHR) at Buy